| Cancer–testis genes as candidates for immunotherapy in breast cancer S Ghafouri-Fard, R Shamsi, M Seifi-Alan, M Javaheri, S Tabarestani Immunotherapy 6 (2), 165-179, 2014 | 50 | 2014 |
| Cancer stem cells and response to therapy S Tabarestani, S Ghafouri-Fard Asian pacific journal of cancer prevention 13 (12), 5947-5954, 2012 | 46 | 2012 |
| New developments in chronic myeloid leukemia: implications for therapy S Tabarestani, A Movafagh Iranian journal of cancer prevention 9 (1), 2016 | 20 | 2016 |
| Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification S Tabarestani, SMH Ghaderian, H Rezvani, R Mirfakhraie, A Ebrahimi, ... Cellular Oncology 37, 107-118, 2014 | 19 | 2014 |
| Detection of gene amplification by multiplex ligation-dependent probe amplification in comparison with in situ hybridization and immunohistochemistry S Tabarestani, SMH Ghaderian, H Rezvani Asian Pacific Journal of Cancer Prevention 16 (17), 7997-8002, 2015 | 14 | 2015 |
| Expression profiling of breast cancer patients treated with tamoxifen: prognostic or predictive significance S Tabarestani, SMH Ghaderian, H Rezvani, R Mirfakhraie Medical Oncology 31, 1-6, 2014 | 13 | 2014 |
| Are estrogen receptor genomic aberrations predictive of hormone therapy response in breast cancer? S Tabarestani, M Motallebi, ME Akbari Iranian Journal of Cancer Prevention 9 (4), 2016 | 12 | 2016 |
| Analysis of BRCA1/2 mutations and performance of manchester scoring system in high risk Iranian breast cancer patients: A pilot study S Tabarestani, M Motallebi, ME Akbari, MM Moghani, L Shojaee International Journal of Cancer Management 10 (12), 2017 | 6 | 2017 |
| Evaluation of PKM2 and MAPK8IP2 polymorphism in Ameloblastic Carcinoma: A retrospective quantitative study A Khodayari, SMH Ghaderian, M Jafarian, A Jahangirnia, A Nayebi, ... International Journal of Molecular and Cellular Medicine 1 (4), 203, 2012 | 3 | 2012 |
| Novel approaches to immunotherapy in triple negative breast cancer S Tabarestani, M Esmaeil-Akbari, S Namaki International Journal of Cancer Management 11 (12), 2018 | 2 | 2018 |
| Genomics role in cancer immunosurveillance: Impact on immunotherapy response S Tabarestani, M Esmaeil-Akbari, S Namaki International Journal of Cancer Management 11 (11), 2018 | 1 | 2018 |
| Analysis of BRCA1/2 Mutations and Performance of Manchester Scoring System in High Risk Iranian Breast Cancer Patients: A Pilot Study L Shojaee, MM Moghani, ME Akbari, S Tabarestani Brieflands, 2017 | | 2017 |
| Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer? M Motallebi, ME Akbari, S Tabarestani Brieflands, 2016 | | 2016 |
| Tumor Profiling as a Predictor of Response to Immunotherapy in Colorectal Cancer S Tabarestani, M Motallebi | | 2016 |
| Gene Amplification Detection by Multiplex Ligation-Dependent Probe Amplification in Comparison with in Situ Hybridization and Immunohistochemistry S Tabarestani, S Ghaderian, H Rezvani JOURNAL OF MOLECULAR DIAGNOSTICS 16 (6), 746-746, 2014 | | 2014 |
| Analysis of copy number alterations (CNAs) in tamoxifen-resistant breast cancer patients S Tabarestani, SMH Ghaderian, H Rezvani, R Mirfakhraie, A Ebrahimi, ... | | 2014 |
| Evaluation of PKM2 and MAPK8IP2 Polymorphism in Ameloblastic Carcinoma: A Retrospective Quantitative Study AM Nayebi, N Taghavi, S Tabarestani, A Khojasteh | | |
